Assessment of the interventional neuroradiology workforce in the United States: A review of the existing data

American Journal of Neuroradiology

Volumn 23, Issue 10, 2002, Pages 1700-1705

  Cloft, Harry J ^a   Tomsick, Thomas A ^a   Kallmes, David F ^a   Goldstein, Jonas H ^a   Connors, John J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL EMBOLISM; BLOOD CLOT LYSIS; BRAIN ARTERY ANEURYSM; CONTINUING EDUCATION; ENDOVASCULAR SURGERY; INTERVENTIONAL RADIOLOGY; MEDICAL EDUCATION; MEDICAL SPECIALIST; NEURORADIOLOGY; REPERFUSION; REVIEW; STENT; STROKE; UNITED STATES;

CEREBROVASCULAR DISORDERS; EDUCATION, MEDICAL, GRADUATE; HUMANS; NEUROSURGERY; RADIOLOGY, INTERVENTIONAL; UNITED STATES; VASCULAR SURGICAL PROCEDURES;

EID: 0036846188     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Higashida RT, Hopkins LN, Berenstein A, Halbach VV, Kerber C. Program requirements for residency/fellowship education in neuroendovascular surgery/interventional neuroradiology: A special report on graduate medical education. AJNR Am J Neuroradiol 2000;21:1153-1159
2. Canto JG, Every NR, Magid DJ, et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. N Engl J Med 2000;342:1573-1580
3. Edwards EB, Roberts JP, McBride MA, Schulak JA, Hunsicker LG. The effect of the volume of procedures at transplantation centers on mortality after liver transplantation. N Engl J Med 1999;341:2049-2053
4. Graduate Medical Education Advisory Committee. Report to the Graduate Medical Education Advisory Committee: Summary report. In: Services. Washington: U.S. Department of Health and Human Services; 1981
5. Council on Graduate Medical Education. Improving Access to Health Care Through Physician Workforce Reform: Directions for the 21st Century: 3rd Report to Congress and the Health and Human Services Secretary. Rockville: Health and Human Services Administration; 1992
6. Ullyot DJ. President's page: Work force issues in cardiology. J Am Coll Cardiol 1995;25:278-279
7. Goldstein S, Alpert JS. The cardiovascular work force: Too large for the future? Am J Cardiol 1994;74:394-395
8. Conti CR. Are there too many cardiologists? A cardiologist's opinion. Clin Cardiol 1995;18:119-121
9. Moore FI, Brundage BH, Adolph RJ, et al. Data bases and methods for adult cardiology manpower analysis-a critical review. JAm Coll Cardiol 1988;12:836-840
10. Beller GA, Vogel RA. Are we training too many cardiologists? Circulation 1997;96:372-378
11. Covey AM, Sunshine J, Forman HP. The job market in diagnostic radiology 1999: Updated findings from a help wanted index of job advertisements. AJR Am J Roentgenol 2000;175:957-961
12. Covey AM, Sunshine J, Forman HP. Changes in the job market for interventional radiology as detected through a help-wanted index of job advertisements. Acad Radiol 2001;8:175-181
13. Goodman DC, Fisher ES, Bubolz TA, Mohr JE, Poage JF, Wennberg JE. Benchmarking the US physician workforce. An alternative to needs-based or demand-based planning. JAMA 1996;276:1811-1817
14. Skolnick BE. Guidelines for acute stroke treatment centers. Phys Med Rehabil Clin N Am 1999;10:801-813
15. Emergency brain resuscitation: A working group on emergency brain resuscitation. Ann Intern Med 1995;122:622-627
16. Allder SJ, Moody AR, Martel AL, et al. Limitations of clinical diagnosis in acute stroke. Lancet 1999;354:1523
17. Sunshine JL, Tarr RW, Lanzieri CF, Landis DM, Selman WR, Lewin JS. Hyperacute stroke: Ultrafast MR imaging to triage patients prior to therapy. Radiology 1999;212:325-332
18. Suarez JI, Sunshine JL, Tarr R, et al. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999;30:2094-2100
19. Albers GW. Expanding the window for thrombolytic therapy in acute stroke: The potential role of acute MRI for patient selection. Stroke 1999;30:2230-2237
20. Hospital and prehospital resources for optimal care of the injured patient: Committee on Trauma of the American College of Surgeons. Bull Am Coll Surg 1986;71:4-23
21. Menghini VV, Brown RD Jr, Sicks JD, O'Fallon WM, Wiebers DO. Incidence and prevalence of intracranial aneurysms and hemorrhage in Olmsted County, Minnesota, 1965 to 1995. Neurology 1998;51:405-411
22. Sacchetti ML, Toni D, Fiorelli M, Argentino C, Fieschi C. The concept of combination therapy in acute ischemic stroke. Neurology 1997;49:S70-S74
23. Antman EM, Giugliano RP, Gibson CM, et al. Abciximab facilitates the rate and extent of thrombolysis: Results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation 1999;99:2720-2732
24. Ohman EM, Kleiman NS, Gacioch G, et al. Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo- controlled, dose-ranging trial. IMPACT-AMI Investigators. Circulation 1997;95:846-854
25. Opatowsky MJ, Morris PP, Regan JD, Mewborne JD, Wilson JA. Rapid thrombectomy of superior sagittal sinus and transverse sinus thrombosis with a rheolytic catheter device. AJNR Am J Neuroradiol 1999;20:414-417
26. Dowd CF, Malek AM, Phatouros CC, Hemphill JC III. Application of a rheolytic thrombectomy device in the treatment of dural sinus thrombosis: A new technique. AJNR Am J Neuroradiol 1999;20: 568-570
27. Ueda T, Hatakeyama T, Kohno K, Kumon Y, Sakaki S. Endovascular treatment for acute thrombotic occlusion of the middle cerebral artery: Local intra-arterial thrombolysis combined with percutaneous transluminal angioplasty. Neuroradiology 1997;39:99-104
28. Ueda T, Sakaki S, Nochide I, Kumon Y, Kohno K, Ohta S. Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries. Stroke 1998;29:2568-2574
29. Nakayama T, Tanaka K, Kaneko M, Yokoyama T, Uemura K. Thrombolysis and angioplasty for acute occlusion of intracranial vertebrobasilar arteries: Report of three cases. J Neurosurg 1998;88:919-922
30. Barnwell SL, Clark WM, Nguyen TT, O'Neill OR, Wynn ML, Coull BM. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR Am J Neuroradiol 1994;15:1817-1822
31. Jahan R, Duckwiler GR, Kidwell CS, et al. Intraarterial thrombolysis for treatment of acute stroke: Experience in 26 patients with long-term follow-up. AJNR Am J Neuroradiol 1999;20:1291-1299
32. Hill MD, Barber PA, Demchuk AM, et al. Acute intravenous intra-arterial revascularization therapy for severe ischemic stroke. Stroke 2002;33:279-282
33. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-2011
34. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4-11
35. Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598-2605
36. Lacy CR, Suh DC, Bueno M, Kostis JB. Delay in presentation and evaluation for acute stroke: Stroke Time Registry for Outcomes Knowledge and Epidemiology (S.T.R.O.K.E.). Stroke 2001;32:63-69
37. Morgenstern LB, Staub L, Chan W, et al. Improving Delivery of Acute Stroke Therapy: The TLL Temple Foundation Stroke Project. Stroke 2002;33:160-166
38. Riopelle RJ, Howse DC, Bolton C, et al. Regional access to acute ischemic stroke intervention. Stroke 2001;32:652-655
39. Williams GR, Jiang JG, Matchar DB, Samsa GP. Incidence and occurrence of total (first-ever and recurrent) stroke. Stroke 1999; 30:2523-2528
40. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999;282:2019-2026
41. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-1587
42. Chiu D, Krieger D, Villar-Cordova C, et al. Intravenous tissue plasminogen activator for acute ischemic stroke: Feasibility, safety, and efficacy in the first year of clinical practice. Stroke 1998;29:18-22
43. Zweifler RM, Brody ML, Graves GC, et al. Intravenous t-PA for acute ischemic stroke: Therapeutic yield of a stroke code system. Neurology 1998;50:501-503